JAK2 and lung carcinoma: Notably, although the IL-6/JAK2/STAT3 axis is generally recognized as a tumor-promoting signaling loop in the progression of lung cancer, its effect in the initiation of lung carcinogenesis remains controversial because IL-6 prevents the initiation of lung carcinogenesis, as evidenced by Qu et al. [41].